Create an account
-inhibits synthesis of bacterial cell walls by inhibitings cross-linkage between peptidoglycan polymer chains that make up the cell walls of both gram + & -
-inhibits cell wall synthesis; acids (-); orally active.
-procaine PG and benzathine PG are repository forms with slow abs.
-PenV is orally active as Na+ or K+ salt - risk of hypo and hyper kalemia respectively
-binds large ribosomal subunit and directly interferes with substrate binding, blocks protein production, bacteriostatic
-crosses BBB, accumulates in CNS
-not used in the US due to AEs of aplastic and erythrocytic anemias and others
-inhibits DNA gyrase (type II topoisomerase), inhibiting cell division
-active against both gram + & -
-orally active, well absorbed into most hard-to-access areas but NOT CNS (urinary tract, reproductive, bone)
-tx for UTIs, prostate, bone infections
-affects mammalian cell replication also
-crosslinks DNA (alkylating agent)
-cell cycle phase nonspecific
-administered IV short term
-binds small ribosomal subunit, inhibits peptide bond formation
-more effective against gram -
-usu combined w/ PCN abx to overcome antibiotic resistance (restore activity of beta-lactam ring
-suicide inhibitor, covalently binds active site
-Crosslinks DNA irreversibly
-prodrug, converted by P450 dependent pathway to active phosphoramide mustard. This metabolite only forms in cells with low ALDH levels.
-tx of lymphomas, leukemia and solid tumors
-orally active unlike most alkylating agents due to P450 metabolism
-causes marked and persistent cholinesterase activity.
-also stabilizes topoisomerase II complex after it has broken the DNA chain for replication (DNA can't be "resealed")
-substrate for oxidative metabolism and superozide radical production
-cell cycle nonspecific
-administered IV, often in combo w/ other agents
-etabolized by P450 into active and inactive metabolites. .
-reversibly binds 30S ribosome and inhibits transpeptidation
-hepatic metabolism, significant enterohepatic recirculation
-relatively long acting
-can produce photosensitivity
-macrolide, binds 50S ribosome subunit
-easily inactivated by gastric acid, therefore all oral formulations have enteric coating
-good alternative to PCN
-major AE diarrhea
-inhibits topoisomerase II, promotes cellular apoptosis (ca tx)
-late S & G2 phase specific
-converted to 5-FdUMP which inhibits thymidylate synthase. RNA/protein synthesis not affected. Results in unbalanced cell growth
-given IV (poor oral bioavailability due to first pass met)
gentamicin and tobramycin
-binds small ribosomal subunit (AG)
-mostly effective against gram (-) aerobic bugs (uptake is O2 dependent)
-IV, IM, topical (not orally active, not absorbed)
-McAb that binds HER2/neu receptor, down-regulates expression and arrests cell cycle
-tx for breast cancer.
-inhibitor of TK enzymes, binds near ATP binding site of enzyme locking it in a closed or self-inhibited conformation,
leucovorin (folinic acid)
-derivative of THF, vitamin activity equivalent to FA but does not require DHFR for conversion. Allows purine/pyrimidine synthesis in the presence of dihydrofolate reductase inhibition (for ca tx), so some normal DNA replication and RNA transcription processes can proceed.
-inhibits DHFR (converts DHF to active THF), decreases T and purine NT levels.
- variable oral absorption, active uptake into cells, intrathacal for CNS treatment
-lethal at high doses requiring antidotal therapy using folinic acid and leucovorin. Intratheral for CNS treatment
-RENAL EXCRETION - may require dose adjustment.
-Prevents mitotic spindle assembly, chromosome segregation & cell division. Stabilizes microtubule polymer and protects it from disassembly, leads to a mitotic block and apoptosis.
-sed for breast, ovarian and lung cancer.
-Competitive antagonists of PABA synthesis, reduces precursors for DNA synthesis
-high PPB (80-90%)
-Administered 1:5 with trimethoprim (TMP/SMX) resulting in 1:20 plasma concentration due to larger Vd of TMP and low PPB
-can displace bilirubin binding in neonates = hyperbilirubinemia
-potentites actions of pheyntion and warfarin.
-estrogen receptor antagonist in breast, in other tissues may act as an agonist
-causes cells to remain in the G0/G1
-prodrug, metabolized by CYP2D6/3A4
-tx for estrogen-related ca
-competitively inhibits DHFR (DHF --> THF) reduces precursors for synthesis of DNA, RNA, thymidylates, and protein
-BASIC drug, accumulates in acidic fluids of prostate (ion trapping) but due to duration of tx required for effect prostate infections more commonly treated w/ quinolones
-Administered 1:5 with sulfamethoxazole resulting in 1:20 plasma concentration (TMP/SMX) due to larger Vd of TMP and low PPB
-disrupts microtubule assembly, disrupting mitotic spindle
-M phase specific
--different spectrum of clinical activity and toxicity compared to vincristine
-AEs include n/v bone marrow suppression, alopecia
Please allow access to your computer’s microphone to use Voice Recording.
Having trouble? Click here for help.
We can’t access your microphone!
Click the icon above to update your browser permissions and try again
Reload the page to try again!Reload
Press Cmd-0 to reset your zoom
Press Ctrl-0 to reset your zoom
It looks like your browser might be zoomed in or out. Your browser needs to be zoomed to a normal size to record audio.
Please upgrade Flash or install Chrome
to use Voice Recording.
For more help, see our troubleshooting page.
Your microphone is muted
For help fixing this issue, see this FAQ.
Star this term
You can study starred terms together